Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

Description

This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.

Conditions

Acute Leukemia, Leukemia

Talk to us

Study Overview

On this page

Study Details

Study overview

This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.

Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

Condition
Acute Leukemia
Intervention / Treatment

-

Contacts and Locations

Boston

Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 or older
  • * English speaking
  • * Ability to understand and willingness to sign written informed consent
  • * Clinical suspicion of acute leukemia
  • * Admitted to DFCI-affiliated inpatient unit
  • * Cognitive impairment rendering the individual unable to participate in beta testing
  • * This will be assessed by focused chart review and consultation with the patients' inpatient care team.
  • * The following populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers \<18 years old), prisoners.
  • * Inability to participate in in-person application testing.
  • * Patients who participated in alpha-testing through protocol 23-404 (Appendix A)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dana-Farber Cancer Institute,

Andrew Hantel, MD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

2026-12-01